(Q43566991)

24 November 2017

The prognostic relevance of miR-212 expression with survival in cytogenetically and molecularly heterogeneous AML. (English)

1 reference

24 November 2017

S M Sun

1

1 reference

24 November 2017

V Rockova

2

1 reference

24 November 2017

L Bullinger

3

1 reference

24 November 2017

M K Dijkstra

4

1 reference

24 November 2017

H Döhner

5

1 reference

24 November 2017

B Löwenberg

6

1 reference

24 November 2017

M Jongen-Lavrencic

7

1 reference

24 November 2017

13 June 2012

1 reference

24 November 2017

1 reference

24 November 2017

27

1 reference

24 November 2017

1

1 reference

24 November 2017

100-106

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2012.158

24 November 2017

0 references

cites work

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

DNMT3A Mutations in Acute Myeloid Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CAL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

MicroRNAs: emerging key regulators of hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

MicroRNA expression in cytogenetically normal acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

MicroRNA 29b functions in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

Role of chemokines in the biology of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

The chemokine system: a possible therapeutic target in acute graft versus host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

Down-regulation of miR-212 expression by DNA hypermethylation in human gastric cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

High Expression Levels of theETS-Related Gene,ERG, Predict Adverse Outcome and Improve Molecular Risk-Based Classification of Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

7 January 2021

Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

7 January 2021

High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

7 January 2021

Risk stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markers

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

7 January 2021

Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

7 January 2021

Transition of highly specific microRNA expression patterns in association with discrete maturation stages of human granulopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

7 January 2021

MicroRNA signatures characterize multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

7 January 2021

MicroRNA Expression Profiles in Umbilical Cord Blood Cell Lineages

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

7 January 2021

Acute myeloid leukaemia triggering via CD40 induces leukocyte chemoattraction and cytotoxicity against allogenic or autologous leukemic targets

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

7 January 2021

Role of urokinase plasminogen activator receptor (CD87) as a prognostic marker in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.158

7 January 2021

Identifiers

DOI

10.1038/LEU.2012.158

1 reference

Dimensions Publication ID

24 November 2017

0 references

1 reference